Pilocytic astrocytoma: pathology, molecular mechanisms and markers.
Collins VP, Jones DT, Giannini C. · 2015
Read Pilocytic astrocytoma: pathology, molecular mechanisms and markers. by Collins VP, Jones DT, Giannini C. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4436848.txt.
Description
V Peter Collins, David Jones, and Caterina Giannini reviewed pilocytic astrocytoma in Acta Neuropathologica in 2015. These brain tumors, recognized as a distinct kind more than seventy years earlier, are classed as low grade and most patients live long after treatment. Many need only surgical removal, and they rarely turn into aggressive cancers, though some look deceptively like more dangerous gliomas under the microscope.
Genome-wide sequencing changed the picture of their cause. Nearly all cases carry a single fault in one signaling route, the MAPK pathway, which controls cell growth. The most common fault joins part of one gene, KIAA1549, to the active part of another, BRAF, creating a fused protein that drives growth. Rarer partners and related faults in growth receptors also occur. The review uses these markers to sharpen diagnosis and sort hard cases.
Catalog record
| CREATOR | Collins VP, Jones DT, Giannini C. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 53 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |